RUA Life Sciences (LON:RUA) Trading Up 9.3% – Should You Buy?

RUA Life Sciences plc (LON:RUAGet Free Report) traded up 9.3% during mid-day trading on Thursday . The stock traded as high as GBX 19.70 and last traded at GBX 19.68. 232,569 shares were traded during trading, a decline of 13% from the average session volume of 267,222 shares. The stock had previously closed at GBX 18.

RUA Life Sciences Price Performance

The company has a debt-to-equity ratio of 18.95, a current ratio of 4.64 and a quick ratio of 7.32. The company’s 50-day simple moving average is GBX 18.34 and its 200-day simple moving average is GBX 15.05. The stock has a market capitalization of £12.19 million, a P/E ratio of -2.61 and a beta of 0.97.

RUA Life Sciences Company Profile

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Recommended Stories

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.